This multi-faceted action makes it a powerful tool for metabolic health
(2020) Narrative review: Nutrient deficiencies in adults and children with treated and untreated celiac disease, Nutrients, Vol
At True Health Preventative Care, we are committed to supporting you every step of the way on your weight loss journey
Administration This information reflects common protocols used in non-FDA regulated research settings and is for informational purposes only
L cell secretagogues Stimulation of GLP-1 secretion from enteroendocrine L cells is another approach that may be able to realise the therapeutic potential of GLP-1, perhaps in combination with DPP-4 inhibition to prevent the inactivation of the GLP-1 released
Market Players, Key Developments, and Competitive Intelligence To learn more about this report, Key Developments On June 30, 2025, Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on peptide-based therapeutics, announced the nomination of PN-477, a triple agonist peptide targeting GLP-1, GIP, and GCG receptors, for obesity treatment